Design and synthesis of macrocycles active against vancomycin-resistant enterococci (VRE): the interplay between D-Ala-D-Lac binding and hydrophobic effect
A modified vancomycin binding pocket (D-O-E ring) incorporating a CHNHCOR function at the AA4 position is designed and synthesized. Potent bioactivities against both sensitive- and resistant-strain are found for some of these compds. (MIC 4 micro g/mL against VREF). From this preliminary SAR studies, it was speculated that the D-Ala-D-Ala binding was required for this series of compds. since the corresponding des-leucine deriv. is inactive. The presence of long aliph. chain was important for the desired activities and such hydrophobic effect is specific as no beneficial effect is obsd. when the same aliph. chain was attached to the other part of the mol. [on SciFinder (R)]
Cite this item
Ma, N., Jia, Y., Liu, Z., Gonzalez-Zamora, E., Bois-Choussy, M., Malabarba, A., Brunati, C., & Zhu, J. (2005). Design and synthesis of macrocycles active against vancomycin-resistant enterococci (VRE): the interplay between D-Ala-D-Lac binding and hydrophobic effect. Bioorganic & Medicinal Chemistry Letters, 15(3), 743–746. https://doi.org/10.1016/j.bmcl.2004.11.014
Click Copy to copy the citation, or select the text manually.
2005
15
3
743
746
CAN 142:298321
34-3
Amino Acids, Peptides, and Proteins
Institut de Chimie des Substances Naturelles, CNRS,Gif-sur-Yvette,Fr.
Journal
written in English.
847505-77-5P Role: RCT (Reactant), SPN (Synthetic preparation), PREP (Preparation), RACT (Reactant or reagent) (synthesis by azide redn. followed by SNAr-based macrocyclization via biaryl ethers and structure-activity relationship against vancomycin-resistant enterococci of macrocyclic glycopeptides); 847599-46-6P Role: PAC (Pharmacological activity), RCT (Reactant), SPN (Synthetic preparation), BIOL (Biological study), PREP (Preparation), RACT (Reactant or reagent) (synthesis via SNAr-based macrocyclization and glycosylation and structure-activity relationship against vancomycin-resistant enterococci of macrocyclic glycopeptides); 847505-79-7P; 847599-40-0P; 847599-42-2P; 847599-43-3P; 847599-47-7P; 847599-48-8P; 847599-49-9P; 847599-62-6P; 847599-63-7P; 847599-71-7P Role: PAC (Pharmacological activity), SPN (Synthetic preparation), BIOL (Biological study), PREP (Preparation) (synthesis via SNAr-based macrocyclization and glycosylation and structure-activity relationship against vancomycin-resistant enterococci of macrocyclic glycopeptides); 143-07-7 (n-Dodecanoic acid) Role: RCT (Reactant), RACT (Reactant or reagent) (synthesis via SNAr-based macrocyclization and glycosylation and structure-activity relationship against vancomycin-resistant enterococci of macrocyclic glycopeptides); 847505-78-6P; 847599-37-5P; 847599-38-6P; 847599-39-7P Role: RCT (Reactant), SPN (Synthetic preparation), PREP (Preparation), RACT (Reactant or reagent) (synthesis via SNAr-based macrocyclization and glycosylation and structure-activity relationship against vancomycin-resistant enterococci of macrocyclic glycopeptides); 1404-90-6DP (Vancomycin) Role: PAC (Pharmacological activity), RCT (Reactant), SPN (Synthetic preparation), BIOL (Biological study), PREP (Preparation), RACT (Reactant or reagent) (synthesis via SNAr-based macrocyclization and glycosylation and structure-activity relationship against vancomycin-resistant enterococci of vancomycin-type macrocyclic glycopeptides)
REVIEWED
OTHER